Abstract:Background It has been postulated that non-steroidal anti-inflammatory drugs (NSAIDs) use leads to decreased prostate cancer (PCa) risk. In recent years, NSAIDs’ role in PCa development has been extensively studied; however, there is not yet a definitive answer. Moreover, the epidemiological results for NSAIDs’ effect on PCa-specific mortality have been inconsistent. Therefore, we performed a meta-analysis to examine the controversy. Methods We performed a literature database search and included all published studies conducted in the general population exposed to any NSAID, extracting an odds ratio (OR) or a hazard ratio (HR) with 95% confidence intervals (95% CIs) that compared the incidence of PCa or PCa-specific mortality with non-exposure. We derived a pooled OR or HR using random or fixed effects models, as appropriate. Subgroup analyses were also performed. Results Thirty-nine studies (20 case–control and 19 cohort studies) were included in this analysis. Thirty-one studies were available concerning NSAID use and PCa incidence and eight studies on PCa-specific mortality. Compared to non-use, aspirin use was statistically significantly associated with PCa incidence risk, and the association was slightly stronger for advanced PCa than for total PCa (OR = 0.92, 95% CI = 0.87 to 0.97 for total PCa; OR = 0.81, 95% CI = 0.73 to 0.89 for advanced PCa). Aspirin use seems also to be associated with a modest reduction in PCa-specific mortality (HR = 0.86, 95% CI = 0.78 to 0.96 for total PCa; OR = 0.81, 95% CI = 0.71 to 0.92 for advanced PCa). Generally, the pooled effects for any NSAIDs, NA-NSAIDs and cyclooxygenase-2 inhibitors demonstrated no adverse or beneficial effects on PCa development or PCa-specific mortality, but the results were not consistent. The effect estimates did not vary markedly when stratified by study design and study quality but varied by geographic region. Furthermore, long-term aspirin use (≥4 years) was also significantly associated with reduced PCa incidence (OR = 0.88, 95% CI 0.79 to 0.99). Conclusions The present meta-analysis provides support for the hypothesis that aspirin use is inversely related to PCa incidence and PCa-specific mortality. The effect estimates, varying by geographic region, deserve further investigation.

Association Between Nonsteroidal Anti-Inflammatory Drugs Use and Risk of Central Nervous System Tumors: a Dose-Response Meta Analysis

Meta-analysis on the Relationship Between Nonsteroidal Anti-Inflammatory Drug Use and Gastric Cancer.

Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis

The relationship between nonsteroidal anti-inflammatory drugs and cancer incidence: An umbrella review

The relationship between consumption of nitrite or nitrate and risk of non-Hodgkin lymphoma

Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis.

Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk.

Nonsteroidal Anti-Inflammatory Drug Use and the Risk of Melanoma

Use of non-steroidal antiinflammatory drug and colorectal polyps: a systematic review and Meta-analysis

Head and neck cancer and non‐steroidal anti‐inflammatory drugs: Systematic review and meta‐analysis

Meta-analysis of Nonsteroidal Anti-Inflammatory Drug Intake and Prostate Cancer Risk

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis

NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies

Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization

Risks of Colorectal Neoplasms and Cardiovascular Thromboembolic Events after the Combined Use of Selective COX-2 Inhibitors and Aspirin with 5-Year Follow-Up: a Meta-Analysis

Prevalence of NSAID Use among People with COVID‐19 and the Association with COVID‐19‐related Outcomes: Systematic Review and Meta‐analysis

Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies

Use of Ibuprofen and Risk of Parkinson Disease

Association of Non-Steroidal Anti-Inflammatory Drugs, Genetic Risk, and Environmental Risk Factors with Incidence of Colorectal Cancer.

Use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk in the Women's Health Initiative

Non-steroidal Anti-Inflammatory Drugs, Polygenic Risk Score and Colorectal Cancer Risk.